Depression

Antidepressant drug pulled in Europe

Published in Medical Letter on the CDC and FDA, February 2nd, 2003

British regulators said January 8, 2003, that Bristol-Myers Squibb Co. would voluntarily stop selling its antidepressant Dutonin in Europe. The drug, called Serzone in the United States, has been linked to liver failure.

In a statement, the U.K. Medicines Control Board said that "as of December 2002, worldwide there have been 26 reports of liver failure. ... Of these, there were 10 cases involving liver transplant and 13 deaths (5 in patients following liver transplant)."

Bristol-Myers spokesman Rob Hutchinson confirmed that the company will stop selling the drug in the European Union countries where it's currently marketed, but said there are no...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA

Source: Medical Letter on the CDC and FDA (2003-02-02)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry